We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.2B
AUM Growth
+$2.05B
Cap. Flow
+$2.63B
Cap. Flow %
18.56%
Top 10 Hldgs %
24.41%
Holding
915
New
139
Increased
425
Reduced
186
Closed
46

Sector Composition

Rank Sector Weight
1 Healthcare 31.77%
2 Technology 24.47%
3 Financials 9.64%
4 Consumer Discretionary 7.95%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADV icon
801
Advantage Solutions
ADV
$504M
$406K ﹤0.01%
+7,626
New +$703K
GWRE icon
802
Guidewire Software
GWRE
$12.4B
$402K ﹤0.01%
+6,531
New +$472K
TXG icon
803
10x Genomics
TXG
$5.83B
$399K ﹤0.01%
14,000
-10,000
-42% -$381K
DASH icon
804
DoorDash
DASH
$80.3B
$396K ﹤0.01%
8,011
-1,777
-18% -$119K
FNV icon
805
Franco-Nevada
FNV
$41.4B
$389K ﹤0.01%
3,243
SEER icon
806
Seer Inc
SEER
$108M
$387K ﹤0.01%
50,000
COUP
807
DELISTED
Coupa Software Incorporated
COUP
$385K ﹤0.01%
+6,543
New +$429K
SBNY
808
DELISTED
Signature Bank
SBNY
$381K ﹤0.01%
2,522
-5,388
-68% -$979K
CGNX icon
809
Cognex
CGNX
$10.2B
$359K ﹤0.01%
8,671
BEPC icon
810
Brookfield Renewable
BEPC
$5.95B
$349K ﹤0.01%
+10,629
New +$409K
CCL icon
811
Carnival Corporation Ltd
CCL
$37.1B
$337K ﹤0.01%
47,998
-9,939
-17% -$96.3K
NUVB icon
812
Nuvation Bio
NUVB
$2.32B
$314K ﹤0.01%
140,129
-180,835
-56% -$516K
RNG icon
813
RingCentral
RNG
$4.5B
$313K ﹤0.01%
7,829
-31,800
-80% -$1.52M
MOR
814
DELISTED
MorphoSys AG American Depositary Shares
MOR
$292K ﹤0.01%
58,169
NHI icon
815
National Health Investors
NHI
$3.84B
$283K ﹤0.01%
5,000
ZION icon
816
Zions Bancorporation
ZION
$10B
$272K ﹤0.01%
5,346
HII icon
817
Huntington Ingalls Industries
HII
$11.4B
$254K ﹤0.01%
1,147
Z icon
818
Zillow
Z
$7.32B
$240K ﹤0.01%
8,380
-2,732
-25% -$94.9K
IP icon
819
International Paper
IP
$22.5B
$237K ﹤0.01%
7,485
CVE icon
820
Cenovus Energy
CVE
$52.3B
$233K ﹤0.01%
+15,084
New +$268K
ELAN icon
821
Elanco Animal Health
ELAN
$12.7B
$223K ﹤0.01%
17,975
-4,835
-21% -$84.5K
BB icon
822
BlackBerry
BB
$4.93B
$214K ﹤0.01%
+45,117
New +$270K
LSPD icon
823
Lightspeed Commerce
LSPD
$1.35B
$195K ﹤0.01%
+11,028
New +$220K
GFI icon
824
Gold Fields
GFI
$29.4B
$169K ﹤0.01%
20,867
GOOD
825
Gladstone Commercial Corp
GOOD
$627M
$155K ﹤0.01%
10,000

Similar funds

Candriam SCA's Q3 2022 Portfolio in Review

As of Q3 2022, Candriam SCA held 915 positions worth $14.2B, up 17% from $12.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA deployed $2.63B of net new capital in Q3 2022, opening 139 new positions and adding to 425 existing holdings. Its largest new stake was Veru: 378,115 shares worth $43.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Sociedad Química y Minera de Chile, an estimated $60.4M trimmed.

  • Candriam SCA's largest Q3 2022 buy was Veru: 378,115 shares worth $43.6M.
  • Candriam SCA added most to Apple in Q3 2022, an estimated $226M increase.
  • Candriam SCA's biggest Q3 2022 reduction was Sociedad Química y Minera de Chile, cutting an estimated $60.4M.
  • Candriam SCA fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $36.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.2B portfolio in Q3 2022.
  • Candriam SCA opened 139 new positions and closed 46 in Q3 2022.
  • Candriam SCA's portfolio value rose 17% quarter-over-quarter to $14.2B.

Based on Candriam SCA's 13F filing for Q3 2022, filed 10 Nov 2022.